Search
Arcutis Biotherapeutics Inc
ARQTAdd to Watchlist
25.550USD
-1.450-5.37%
Close 11-06 16:00（ET）
3.21BMarket Cap
LossP/E TTM
Today
-5.37%
5 Days
-20.33%
1 Month
+6.81%
6 Months
+5.71%
Year to Date
-12.02%
1 Year
+1.79%
Key Figures
26.700Open
27.090High
395.97KVolume
LossP/E TTM
18.29P/E Dynamic
--Dividend TTM
0.32%Turnover Ratio
27.000Prev. Close
25.290Low
10.15MTurnover
LossP/E Static
13.15P/B
0.00%Div Yield TTM
-0.59%ROA
34.80052wk High
0.13Volume Ratio
-140.04MNet Profit
125.69MShares
-0.0153EPS TTM
1.53Beta
-1.43%ROE
19.29552wk Low
15.56%Amplitude
91.34%Gross Margin
3.21BMarket Cap
-1.59Reward/Risk
3.55%Risk Rate
Arcutis Biotherapeutics Inc's Score
-0.39vs previous score
Forecast8.25
Financial Health7.81
Technical4.56
Valuation Dimensions6.37
Institutional Confidence10.00
Risk Assessment4.32
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Arcutis Biotherapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Arcutis Biotherapeutics Inc Latest Earnings Call Transcripts
Arcutis Biotherapeutics (ARQT) Q3 2026 Earnings Call: Revenue Up 45%, Guidance Raised
Arcutis Biotherapeutics Q3 2026 revenue rose 45% to $143.9 million, prompting higher 2026 guidance of $535 million-$545 million.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.07/0.17
Revenue / Forecast
143.92M/142.59M
Arcutis Biotherapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolARQT
Number of employees342
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Suvretta Capital Management, LLC | 9.56% |
| Frazier Life Sciences Management, L.P. | 7.89% |
| Rubric Capital Management LP | 6.61% |
| BlackRock Institutional Trust Company, N.A. | 6.38% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 33.25% |
| Investment Advisor/Hedge Fund | 30.69% |
| Hedge Fund | 25.66% |
| Private Equity | 8.06% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Arcutis Biotherapeutics Inc (ARQT)?
The current price of Arcutis Biotherapeutics Inc (ARQT) is 25.55.
What is the symbol of Arcutis Biotherapeutics Inc?
The ticker symbol of Arcutis Biotherapeutics Inc is ARQT.
What is the 52-week high of Arcutis Biotherapeutics Inc?
The 52-week high of Arcutis Biotherapeutics Inc is 34.80.
What is the 52-week low of Arcutis Biotherapeutics Inc?
The 52-week low of Arcutis Biotherapeutics Inc is 19.30.
What is the market capitalization of Arcutis Biotherapeutics Inc?
The market capitalization of Arcutis Biotherapeutics Inc is 3.21B.
Is Arcutis Biotherapeutics Inc (ARQT) currently rated as Buy, Hold, or Sell?
According to analysts, Arcutis Biotherapeutics Inc (ARQT) has an overall rating of Buy, with a price target of 39.12.
What is the Earnings Per Share (EPS TTM) of Arcutis Biotherapeutics Inc (ARQT)?
The Earnings Per Share (EPS TTM) of Arcutis Biotherapeutics Inc (ARQT) is -0.02.